|The C-peptide n/a (Catalog #MBS313235) is an Antibody produced from Mouse
Source: Ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s C-peptide can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Lateral Flow (LF).
C-peptide Detection: Suitable for use in competitive ELISA or RIA detection of C-peptide in human serum after immunospecific removal of proinsulin with E01339M or E01338M bound to a solid phase.
Immunosorbent: May be used as a specific immunosorbent of total proinsulin and C-peptide molecules from serum samples before the measurement of human insulin.
Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. Researchers should empirically determine the suitability of the C-peptide n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MAb to C-Peptide
Monoclonal Antibody to C-Peptide.
Buffer: Phosphate Buffered Saline, pH 7.4
Immunogen: Recombinant C-Peptide. Preservative: 0.09% Sodium Azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing C-peptide are readily searchable from our website. Different antibodies against the same target such as C-peptide may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.